The University of Kansas Cancer Center - Overland Park — Overland Park, Kansas

The University of Kansas Cancer Center - Overland Park is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center - Overland Park has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Triple Negative Breast Cancer, Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, University of Kansas Medical Center, Pfizer.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center - Overland Park?

The University of Kansas Cancer Center - Overland Park has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center - Overland Park conducted?

The University of Kansas Cancer Center - Overland Park has 7 clinical trials on record, with 7 currently active. Their work covers HER2-positive Breast Cancer, Triple Negative Breast Cancer, Breast Cancer.

Is The University of Kansas Cancer Center - Overland Park accredited by Crixeo Health?

Yes — The University of Kansas Cancer Center - Overland Park holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Kansas Cancer Center - Overland Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.